The novel therapy of the medication represents a significant breakthrough in the care of the condition. Unlike existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide774360.develop-blog.com/49945757/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment